Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-23-Speech-2-938"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"it"^^xsd:language2
lpv:document identification number	"en.20101123.33.2-938"2
lpv:hasSubsequent	lp_eu:2010-11-23-Speech-2-2202
lpv:speaker	lp:Lara Comi2
lpv:spokenAs	unknown; Il Popolo della Libertà (2009-07-14--2014-01-26)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2010-07-05--2014-06-30)3 substitute; ITRE (2009-07-16--2012-01-18)3 substitute; Delegation to the EU-Russia Parliamentary Cooperation Committee (2009-09-16--2013-04-07)3 member; EPP (2009-07-14--2014-06-30)3 vice-chair; IMCO (2009-07-16--2012-01-18)3 member; Delegation to the EU-Mexico Joint Parliamentary Committee (2010-07-05--2014-06-30)3
lpv:translated text	"I am in favour, on condition that the appropriate scientific tests are carried out and the list of drugs, intermediates and active ingredients covered by the agreement on duty-free treatment is extended. The proposal sends out a strong signal to the markets. In fact, it serves primarily to confirm the commitment of certain important members of the World Trade Organisation to the free market. It also has the effect of extending the boundaries of the potential market for the results of certain scientific research sectors, thereby encouraging investment in those sectors and, with it, the fight against diseases for which there is still no effective cure. Lastly, the proposal sets an example to those countries for which pharmaceuticals represent a necessary item of expenditure if they are to guarantee a future for the younger generations, and a call to take a stance in favour of the adoption of development and wealth creation policies."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph